KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amneal Pharmaceuticals (AMRX) Prepaid Assets: 2017-2025

Historic Prepaid Assets for Amneal Pharmaceuticals (AMRX) over the last 8 years, with Sep 2025 value amounting to $101.5 million.

  • Amneal Pharmaceuticals' Prepaid Assets rose 23.86% to $101.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $101.5 million, marking a year-over-year increase of 23.86%. This contributed to the annual value of $80.7 million for FY2024, which is 2.38% down from last year.
  • Latest data reveals that Amneal Pharmaceuticals reported Prepaid Assets of $101.5 million as of Q3 2025, which was up 19.00% from $85.3 million recorded in Q2 2025.
  • In the past 5 years, Amneal Pharmaceuticals' Prepaid Assets ranged from a high of $232.2 million in Q2 2022 and a low of $75.1 million during Q1 2021.
  • In the last 3 years, Amneal Pharmaceuticals' Prepaid Assets had a median value of $82.7 million in 2023 and averaged $85.8 million.
  • Its Prepaid Assets has fluctuated over the past 5 years, first spiked by 123.71% in 2022, then crashed by 64.79% in 2023.
  • Amneal Pharmaceuticals' Prepaid Assets (Quarterly) stood at $110.2 million in 2021, then decreased by 6.04% to $103.6 million in 2022, then declined by 20.16% to $82.7 million in 2023, then dropped by 2.38% to $80.7 million in 2024, then increased by 23.86% to $101.5 million in 2025.
  • Its last three reported values are $101.5 million in Q3 2025, $85.3 million for Q2 2025, and $88.5 million during Q1 2025.